Follow
Gillian Kolla
Title
Cited by
Cited by
Year
A new realistic evaluation analysis method: linked coding of context, mechanism, and outcome relationships
SF Jackson, G Kolla
American Journal of evaluation 33 (3), 339-349, 2012
1502012
‘It's our safe sanctuary’: experiences of using an unsanctioned overdose prevention site in Toronto, Ontario
A Foreman-Mackey, AM Bayoumi, M Miskovic, G Kolla, C Strike
International Journal of Drug Policy 73, 135-140, 2019
712019
‘It's too much, I'm getting really tired of it’: Overdose response and structural vulnerabilities among harm reduction workers in community settings
G Kolla, C Strike
International Journal of Drug Policy 74, 127-135, 2019
702019
Risk creating and risk reducing: Community perceptions of supervised consumption facilities for illicit drug use
G Kolla, C Strike, TM Watson, J Jairam, B Fischer, AM Bayoumi
Health, Risk & Society 19 (1-2), 91-111, 2017
702017
Police perceptions of supervised consumption sites (SCSs): A qualitative study
TM Watson, A Bayoumi, G Kolla, R Penn, B Fischer, J Luce, C Strike
Substance Use & Misuse 47 (4), 364-374, 2012
612012
Potential cost‐effectiveness of supervised injection facilities in Toronto and Ottawa, Canada
EA Enns, GS Zaric, CJ Strike, JA Jairam, G Kolla, AM Bayoumi
Addiction 111 (3), 475-489, 2016
572016
Interrupting the social processes linked with initiation of injection drug use: results from a pilot study
C Strike, M Rotondi, G Kolla, É Roy, NK Rotondi, K Rudzinski, R Balian, ...
Drug and alcohol dependence 137, 48-54, 2014
572014
Increasing public support for supervised injection facilities in O ntario, C anada
C Strike, JA Jairam, G Kolla, P Millson, S Shepherd, B Fischer, TM Watson, ...
Addiction 109 (6), 946-953, 2014
522014
Changing circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic
T Gomes, R Murray, G Kolla, P Leece, S Bansal, J Besharah
Ontario: Ontario Drug Policy Research Network, 2021
512021
Preventing injection drug use initiation: state of the evidence and opportunities for the future
D Werb, RN Bluthenthal, G Kolla, C Strike, AH Kral, A Uusküla, ...
Journal of Urban Health 95, 91-98, 2018
512018
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm …
S Glegg, K McCrae, G Kolla, N Touesnard, J Turnbull, TD Brothers, R Brar, ...
International Journal of Drug Policy 106, 103742, 2022
482022
Practices of care among people who buy, use, and sell drugs in community settings
G Kolla, C Strike
Harm reduction journal 17, 1-12, 2020
482020
Ambivalence about supervised injection facilities among community stakeholders
C Strike, TM Watson, G Kolla, R Penn, AM Bayoumi
Harm reduction journal 12, 1-5, 2015
482015
A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone
M Perri, N Kaminski, M Bonn, G Kolla, A Guta, AM Bayoumi, ...
Harm reduction journal 18, 1-9, 2021
452021
Critical studies of harm reduction: Overdose response in uncertain political times
TM Watson, G Kolla, E van der Meulen, Z Dodd
International Journal of Drug Policy 76, 102615, 2020
432020
Transition to injection drug use: the role of initiators
NK Rotondi, C Strike, G Kolla, MA Rotondi, K Rudzinski, T Guimond, ...
AIDS and Behavior 18, 486-494, 2014
392014
Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario
T Gomes, G Kolla, D McCormack, A Sereda, S Kitchen, T Antoniou
CMAJ 194 (36), E1233-E1242, 2022
382022
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada
S Young, G Kolla, D McCormack, T Campbell, P Leece, C Strike, ...
International Journal of Drug Policy 102, 103601, 2022
372022
Design considerations for supervised consumption facilities (SCFs): preferences for facilities where people can inject and smoke drugs
TM Watson, C Strike, G Kolla, R Penn, J Jairam, S Hopkins, J Luce, ...
International Journal of Drug Policy 24 (2), 156-163, 2013
372013
The impact of the COVID-19 pandemic on opioid-related harm in Ontario
EL Friesen, PA Kurdyak, T Gomes, G Kolla, P Leece, L Zhu, E Toombs, ...
Science Briefs of the Ontario COVID-19 Science Advisory Table 2 (42), 10.47326, 2021
292021
The system can't perform the operation now. Try again later.
Articles 1–20